Glucose utilization is essential for hypoxia-inducible factor 1α-dependent phosphorylation of c-jun

Molecular and Cellular Biology

Volumn 24, Issue 10, 2004, Pages 4128-4137

  Laderoute, Keith R ^a   Calaoagan, Joy M ^a   Knapp, Merrill ^a   Johnson, Randall S ^b  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; OXYGEN; STRESS ACTIVATED PROTEIN KINASE; THREONINE; TYROSINE; DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; TRANSCRIPTION FACTOR;

ANOXIA; ARTICLE; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOLYSIS; HYPOXIA; OXYGEN SENSING; OXYGENATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; CELL CULTURE; CELL HYPOXIA; CHEMISTRY; GENETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL HYPOXIA; CELLS, CULTURED; DNA; GENE EXPRESSION; GLUCOSE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTORS;

EID: 2942568513     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.10.4128-4137.2004     Document Type: Article

References (66)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
2. Alfranca, A., M. Gutierrez, A. Vara, J. Aragones, F. Vidal, and M. Landazuri. 2002. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol. Cell. Biol. 22:12-22.
3. Ausserer, W. A., B. Bourrat-Floeck, C. J. Green, K. R. Laderoute, and R. M. Sutherland. 1994. Regulation of c-jun expression during hypoxic and low-glucose stress. Mol. Cell. Biol. 14:5032-5042.
4. Bain, J., H. McLauchlan, M. Elliott, and P. Cohen. 2003. The specificities of protein kinase inhibitors: an update. Biochem. J. 371:199-204.
5. Bandyopadhyay, R. S., M. Phelan, and D. V. Faller. 1995. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim. Biophys. Acta 1264:72-78.
6. Barila, D., R. Mangano, S. Gonfioni, J. Kretzschmar, M. Moro, D. Bohmann, and G. Superti-Furga. 2000. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK. EMBO J. 19:273-281.
7. Barnes, K., J. C. Ingram, O. H. Porras, L. F. Barros, E. R. Hudson, L. G. Fryer, F. Foufelle, D. Carling, D. G. Hardie, and S. A. Baldwin. 2002. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115:2433-2442.
8. Barr, R. K., T. S. Kendrick, and M. A. Bogoyevitch. 2002. Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277:10987-10997.
9. Bentley, J., D. Itchayanan, K. Barnes, E. McIntosh, X. Tang, C. P. Downes, G. D. Holman, A. D. Whetton, P. J. Owen-Lynch, and S. A. Baldwin. 2003. Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J. Biol. Chem. 278:39337-39348.
10. 1-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 296:890-896.
11. Chen, E. Y., N. M. Mazure, J. A. Cooper, and A. J. Giaccia. 2001. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res. 61:2429-2433.
12. Conrad, P. W., R. T. Rust, J. Han, D. E. Millhorn, and D. Beitner-Johnson. 1999. Selective activation of p38α and p38γ by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J. Biol. Chem. 274:23570-23576.
13. Das, M., D. M. Bouchey, M. J. Moore, D. C. Hopkins, R. A. Nemenoff, and K. R. Stenmark. 2001. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G protein-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 276:15631-15640.
14. Dickinson, D. A., and H. J. Forman. 2002. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 64:1019-1026.
15. Ebert, B. L., J. D. Firth, and P. J. Ratcliffe. 1995. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem. 270:29083-29089.
16. Grunstein, J., W. G. Roberts, O. Mathieu-Costello, D. Hanahan, and R. S. Johnson. 1999. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59:1592-1598.
17. Hall, J. P., and R. J. Davis. 2002. Analysis of c-Jun N-terminal kinase regulation and function. Methods Enzymol. 345:413-425.
18. Hochachka, P. W., and G. N. Somero. 2002. Biochemical adaptation: mechanism and process in physiological evolution. Oxford University Press, London, United Kingdom.
19. Huang, L. E., and H. F. Bunn. 2003. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278:19575-19578.
20. Hue, L., C. Beauloye, L. Bertrand, S. Horman, U. Krause, A. S. Marsin, D. Meisse, D. Vertommen, and M. H. Rider. 2003. New targets of AMP-activated protein kinase. Biochem. Soc. Trans. 31:213-215.
21. Jin, N., N. Hatton, D. R. Swartz, X. Xia, M. A. Harrington, S. H. Larsen, and R. A. Rhoades. 2000. Hypoxia activates Jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am. J. Respir. Cell Mol. Biol. 23:593-601.
22. Joost, H. G., and B. Thorens. 2001. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol. Membr. Biol. 18:247-256.
23. Kayyali, U. S., C. Donaldson, H. Huang, R. Abdelnour, and P. M. Hassoun. 2001. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J. Biol. Chem. 276:14359-14365.
24. Krishnamachary, B., S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, and G. L. Semenza. 2003. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63:1138-1143.
25. 2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. Cell Growth Differ. 12:137-145.
26. Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-869.
27. Laderoute, K. R., J. M. Calaoagan, C. Gustafson-Brown, A. M. Knapp, G. C. Li, H. L. Mendonca, H. E. Ryan, Z. Wang, and R. S. Johnson. 2002. The response of c-Jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1α dependent. Mol. Cell. Biol. 22:2515-2523.
28. Laderoute, K. R., J. M. Calaoagan, H. L. Mendonca, W. A. Ausserer, E. Y. Chen, A. J. Giaccia, and R. M. Sutherland. 1996. Early responses of SiHa human squamous carcinoma cells to hypoxic signals: evidence of parallel activation of NF-κB and AP-1 transcriptional complexes. Int. J. Oncol. 8:875-882.
29. Laderoute, K. R., H. L. Mendonca, J. M. Calaoagan, A. M. Knapp, A. J. Giaccia, and P. J. Stork. 1999. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J. Biol. Chem. 274:12890-12897.
30. Leppa, S., R. Saffrich, W. Ansorge, and D. Bohmann. 1998. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 17:4404-4413.
31. Lin, A., J. Frost, T. Deng, T. Smeal, N. al-Alawi, U. Kikkawa, T. Hunter, D. Brenner, and M. Karin. 1992. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 71:777-789.
32. Lin, Z., J. M. Weinberg, R. Malhotra, S. E. Merritt, L. B. Holzman, and F. C. Brosius III. 2000. GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am. J. Physiol. Endocrinol. Metab. 278:E958-E966.
33. Lo, L. W., J. J. Cheng, J. J. Chiu, B. S. Wung, Y. C. Liu, and D. L. Wang. 2001. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCα-mediated Ras/Raf-1/ERK1/2 pathway. J. Cell. Physiol. 188:304-312.
34. Mechta-Grigoriou, F., D. Gerald, and M. Yaniv. 2001. The mammalian Jun proteins: redundancy and specificity. Oncogene 20:2378-2389.
35. Minet, E., T. Arnould, G. Michel, I. Roland, D. Mottet, M. Raes, J. Remacle, and C. Michiels. 2000. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468:53-58.
36. Minet, E., G. Michel, D. Mottet, J. P. Piret, A. Barbieux, M. Raes, and C. Michiels. 2001. c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells. Exp. Cell Res. 265:114-124.
37. Moley, K. H., and M. M. Mueckler. 2000. Glucose transport and apoptosis. Apoptosis 5:99-105.
38. Morton, S., R. J. Davis, A. McLaren, and P. Cohen. 2003. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22:3876-3886.
39. Mottet, D., G. Michel, P. Renard, N. Ninane, M. Raes, and C. Michiels. 2003. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol. 194:30-44.
40. Murakami, T., T. Nishiyama, T. Shirotani, Y. Shinohara, M. Kan, K. Ishii, F. Kanai, S. Nakazuru, and Y. Ebina. 1992. Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J. Biol. Chem. 267:9300-9306.
41. Plyte, S. E., K. Hughes, E. Nikolakaki, B. J. Pulverer, and J. R. Woodgett. 1992. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114:147-162.
42. Powis, G., J. R. Gasdaska, and A. Baker, 1997. Redox signaling and the control of cell growth and death. Adv. Pharmacol. 38:329-359.
43. Premkumar, D. R., G. Adhikary, J. L. Overholt, M. S. Simonson, N. S. Cherniack, and N. R. Prabhakar. 2000. Intracellular pathways linking hypoxia to activation of c-fos and AP-1. Adv. Exp. Med. Biol. 475:101-109.
44. Rahmsdorf, H. J. 1996. Jun: transcription factor and oncoprotein. J. Mol. Med. 74:725-747.
45. Rupec, R. A., and P. A. Baeuerle. 1995. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB. Eur. J. Biochem. 234:632-640.
46. Ruscher, K., D. Freyer, M. Karsch, N. Isaev, D. Megow, B. Sawitzki, J. Priller, U. Dirnagl, and A. Meisel. 2002. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22:10291-10301.
47. Rutter, G. A., G. Da Silva Xavier, and I. Leclerc. 2003. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 375:1-16.
48. Sanchez, I., R. T. Hughes, B. J. Mayer, K. Yee, J. R. Woodgett, J. Avruch, J. M. Kyriakis, and L. I. Zon. 1994. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:794-798.
49. Scott, P. H., A. Paul, C. M. Belham, A. J. Peacock, R. M. Wadsworth, G. W. Gould, D. Welsh, and R. Plevin. 1998. Hypoxic stimulation of the stress-activated protein kinases in pulmonary artery fibroblasts. Am. J. Respir. Crit. Care Med. 158:958-962.
50. Seagroves, T. N., H. E. Ryan, H. Lu, B. G. Wouters, M. Knapp, P. Thibault, K. Laderoute, and R. S. Johnson. 2001. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol. Cell. Biol. 21:3436-3444.
51. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3:721-732.
52. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136.
53. Song, M. S., Y. K. Park, J. H. Lee, and K. Park. 2001. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-ε/ERK/AP-1 signaling cascade. Cancer Res. 61:8322-8330.
54. Spitz, D. R., J. E. Sim, L. A. Ridnour, S. S. Galoforo, and Y. J. Lee. 2000. Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann. N. Y. Acad. Sci. 899:349-362.
55. Stoeltzing, O., W. Liu, N. Reinmuth, F. Fan, A. A. Parikh, C. D. Bucana, D. B. Evans, G. L. Semenza, and L. M. Ellis. 2003. Regulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am. J. Pathol. 163:1001-1011.
56. Sun, D., N. Nguyen, T. R. DeGrado, M. Schwaiger, and F. C. Brosius III. 1994. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 89:793-798.
57. Unruh, A., A. Ressel, H. G. Mohamed, R. S. Johnson, R. Nadrowitz, E. Richter, D. M. Katschinski, and R. H. Wenger. 2003. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 22:3213-3220.
58. Vasilevskaya, I. A., and P. J. O'Dwyer. 1999. Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells. Cancer Res. 59:3935-3940.
59. Vogt, P. K. 2001. Jun, the oncoprotein. Oncogene 20:2365-2377.
60. Webster, K. A., D. J. Discher, and N. H. Bishopric. 1993. Induction and nuclear accumulation of Fos and Jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem. 268:16852-16858.
61. 2-regulated gene expression. FASEB J. 16:1151-1162.
62. Widegren, U., J. W. Ryder, and J. R. Zierath. 2001. Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction. Acta Physiol. Scand. 172:227-238.
63. Wisdom, R. 1999. AP-1: one switch for many signals. Exp. Cell Res. 253:180-185.
64. Xu, L., K. Xie, N. Mukaida, K. Matsushima, and I. J. Fidler. 1999. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res. 59:5822-5829.
65. Yao, K. S., S. Xanthoudakis, T. Curran, and P. J. O'Dwyer. 1994. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14:5997-6003.
66. Zudaire, E., A. Martinez, and F. Cuttitta. 2003. Adrenomedullin and cancer. Regul. Pept. 112:175-183.